Natural Alternatives International (NAII) Competitors $3.70 -0.01 (-0.14%) As of 08/8/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAII vs. ADAG, VTGN, BYSI, ORMP, XBIT, VXRT, MGX, EXOZ, ELUT, and EPIXShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Adagene (ADAG), VistaGen Therapeutics (VTGN), BeyondSpring (BYSI), Oramed Pharmaceuticals (ORMP), XBiotech (XBIT), Vaxart (VXRT), Metagenomi (MGX), eXoZymes (EXOZ), Elutia (ELUT), and ESSA Pharma (EPIX). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Its Competitors Adagene VistaGen Therapeutics BeyondSpring Oramed Pharmaceuticals XBiotech Vaxart Metagenomi eXoZymes Elutia ESSA Pharma Natural Alternatives International (NASDAQ:NAII) and Adagene (NASDAQ:ADAG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment. Do analysts recommend NAII or ADAG? Adagene has a consensus price target of $7.50, indicating a potential upside of 245.62%. Given Adagene's stronger consensus rating and higher probable upside, analysts clearly believe Adagene is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Adagene 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in NAII or ADAG? 32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 9.5% of Adagene shares are held by institutional investors. 20.9% of Natural Alternatives International shares are held by insiders. Comparatively, 21.2% of Adagene shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer NAII or ADAG? In the previous week, Adagene had 13 more articles in the media than Natural Alternatives International. MarketBeat recorded 13 mentions for Adagene and 0 mentions for Natural Alternatives International. Adagene's average media sentiment score of 0.67 beat Natural Alternatives International's score of 0.00 indicating that Adagene is being referred to more favorably in the news media. Company Overall Sentiment Natural Alternatives International Neutral Adagene Positive Is NAII or ADAG more profitable? Adagene has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.56%. Adagene's return on equity of 0.00% beat Natural Alternatives International's return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-6.56% -10.34% -5.19% Adagene N/A N/A N/A Which has more volatility & risk, NAII or ADAG? Natural Alternatives International has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Comparatively, Adagene has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Which has preferable valuation & earnings, NAII or ADAG? Natural Alternatives International has higher revenue and earnings than Adagene. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$113.80M0.20-$7.22M-$1.39-2.66Adagene$103.20K990.55-$33.42MN/AN/A SummaryAdagene beats Natural Alternatives International on 12 of the 15 factors compared between the two stocks. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.87M$2.41B$5.49B$9.72BDividend YieldN/A1.78%4.59%4.12%P/E Ratio-2.6620.3930.0524.70Price / Sales0.20725.92458.73100.93Price / CashN/A23.6624.8428.01Price / Book0.285.098.525.76Net Income-$7.22M$31.61M$3.27B$267.05M7 Day Performance-0.27%-2.02%4.65%3.13%1 Month Performance6.02%-0.12%0.96%1.27%1 Year Performance-30.06%5.85%36.43%22.83% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives InternationalN/A$3.70flatN/A-30.1%$22.87M$113.80M-2.66290ADAGAdagene2.9303 of 5 stars$1.89-1.5%$8.00+324.2%-2.7%$88.85M$100K0.00260News CoverageAnalyst ForecastAnalyst RevisionVTGNVistaGen Therapeutics1.2924 of 5 stars$2.91-0.2%N/A-12.9%$86.74M$490K-1.7540Earnings ReportUpcoming EarningsGap UpBYSIBeyondSpringN/A$2.15-0.5%N/A+3.1%$86.69M$1.75M0.0080Upcoming EarningsGap DownORMPOramed Pharmaceuticals0.3058 of 5 stars$2.12+1.4%N/A-10.7%$86.60M$1.34M-4.8210Positive NewsUpcoming EarningsXBITXBiotech0.8271 of 5 stars$2.84-0.4%N/A-55.7%$86.59M$4.01M-2.20100Positive NewsVXRTVaxart2.7071 of 5 stars$0.37flat$3.00+711.0%-34.5%$84.68M$47.40M-1.37120News CoverageUpcoming EarningsMGXMetagenomi2.5906 of 5 stars$2.27-1.5%$13.00+474.0%-33.3%$84.67M$52.29M-1.07236News CoverageUpcoming EarningsEXOZeXoZymesN/A$10.09+1.5%N/AN/A$84.45M$70K0.0029ELUTElutia3.5397 of 5 stars$2.05+3.0%$8.00+290.2%-33.0%$84.30M$24.38M-1.06180Positive NewsEPIXESSA Pharma1.4845 of 5 stars$1.89+0.3%$2.00+6.1%-58.8%$83.68MN/A-2.9950Upcoming Earnings Related Companies and Tools Related Companies Adagene Competitors VistaGen Therapeutics Competitors BeyondSpring Competitors Oramed Pharmaceuticals Competitors XBiotech Competitors Vaxart Competitors Metagenomi Competitors eXoZymes Competitors Elutia Competitors ESSA Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAII) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale